These 2 Stocks Just Declared Dividend Raises That Kick In Next Year. Should You Buy?

It isn't easy to find steady and reliable dividend payers in the pharmaceutical industry. The key reason is simple: Drug development is a frequently laborious and expensive process that can swallow vast amounts of capital. https://www.nasdaq.com/articles/these-2-stocks-just-declared-dividend-raises-kick-next-year-should-you-buy